June 07, 2022
PrEP is an effective way to fight HIV transmission, and more pharmacies are providing this important service.
June 06, 2022
Results address the concern that COVID-19 vaccination might not be effective among those living with HIV.
March 02, 2022
Results of a recent preclinical study provide proof of concept that an mRNA HIV vaccine is safe, immunogenic, and induces CD4–T-cell responses.
January 13, 2022
Administered as an injection every other month, Apretude gives people at risk of contracting HIV a PrEP alternative to taking daily pills.
December 27, 2021
Apretude is approved for use in at-risk adults and adolescent to reduce the risk of sexually acquired HIV.
February 02, 2021
Starting February 11, federal vaccine supplies will be delivered directly to select pharmacies, according to the announcement.
July 13, 2020
The data from a new study has shown that investigational, long-acting injectable cabotegravir boasted a 66% higher efficacy than daily oral pills in preventing HIV-1.
July 09, 2020
Both trial sub-analyses will be presented at the virtual 23rd International AIDS Conference.
July 08, 2020
Survey results on PrEP access and utilization during COVID-19 shelter-in-place orders presented at the 23rd International AIDS Conference.
July 03, 2020
Fostemsavir (Rukobia, ViiV Healthcare) is indicated for use in heavily treatment-experienced adults with multidrug resistant HIV-1 infection.
